Chengdu, China

Haitao Huang


 

Average Co-Inventor Count = 17.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Haitao Huang: Innovator in Biopharmaceuticals from Chengdu**

Introduction

Haitao Huang, an accomplished inventor based in Chengdu, China, has significantly contributed to the field of biopharmaceuticals. With a portfolio of three patents, Huang's work focuses on developing innovative therapeutic methods and compounds that aim to enhance disease treatment and patient outcomes.

Latest Patents

Huang's latest patents showcase his expertise in innovative medical applications. The first patent, titled "Cytotoxin and conjugate, uses of same and preparation method therefor," introduces a novel method for modifying chimeric antigen receptor-modified T cells (CAR-T cells). This method involves expressing an SCFV-CDS TM-4-1BB-CD3 molecule in T cells, which can specifically target and bind to tumor cells exhibiting elevated ROBO1 protein expression, thereby offering potential breakthroughs in preventing and treating tumor-related diseases.

The second patent titled "Polyamide compound and use thereof" presents a polyamide compound characterized by one or more amide bonds formed by the condensation of L-amino acids or D-amino acids. This invention highlights its utility in treating diseases associated with the k-opioid receptor, showcasing several advantages such as improved selectivity, lower addictiveness, and enhanced pharmacokinetic properties, making it a safer choice for patients with fewer side effects.

Career Highlights

Haitao Huang is currently associated with Sichuan Kelun Biotech Biopharmaceutical Co., Ltd., where he continues to push the boundaries of medical science through research and innovation. His work not only emphasizes the importance of novel therapeutic strategies but also has a profound impact on patient care and disease management.

Collaborations

Huang collaborates with a talented team of coworkers, including Jiaqiang Cai and Qiang Tian. Together, they contribute to advancing biopharmaceutical research and development, enhancing the potential for innovative medical solutions.

Conclusion

Haitao Huang's innovative work in the field of biopharmaceuticals demonstrates a dedicated commitment to improving health outcomes through research and invention. With his groundbreaking patents, Huang continues to pave the way for future advancements in therapeutic applications, making a lasting impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…